IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients

Andre Thierry; Taieb Julien

首页> 外文期刊>Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer >IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients

【24h】

IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients

机译：III阶段结肠癌患者的思想研究（佐剂化疗的国际持续时间评估）：减少3个月治疗60％患者的可能性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer》 |2018年第6期|共3页
作者
Andre Thierry; Taieb Julien;
展开▼
作者单位

Hop St Antoine Dept Med Oncol 184 Rue Faubourg St Antoine F-75012 Paris France;

Hop Europeen Georges Pompidou 20 Rue Leblanc F-75015 Paris France;

展开▼
收录信息
原文格式 PDF
正文语种 fre
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients [J] . Andre Thierry, Taieb Julien Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer . 2018,第6期

机译：III阶段结肠癌患者的思想研究（佐剂化疗的国际持续时间评估）：减少3个月治疗60％患者的可能性
2. Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial [J] . Andre Thierry, Vernerey Dewi, Mineur Laurent, Journal of Clinical Oncology . 2018,第15期

机译：三个与6个月的oxaliplatin辅助化疗为III阶段结肠癌患者：无病的生存结果来自随机，开放标签，佐剂国际持续时间评估（想法）法国，第三阶段试验
3. Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for PatientsWith Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial (vol 36, pg 1469, 2018) [J] . Andre Journal of Clinical Oncology . 2018,第18期

机译：三个与6个月的oxaliplatin为基于患者的辅助化疗，患者患者III阶段III结肠癌：无病的生存结果来自随机，开放标签，国际持续时间评估的佐剂（想法）法国，III期试验（Vol 36，PG 1469， 2018年）
4. Adjuvant Chemotherapy Should Not Routinely Be Recommended to Patients with Stage II Colon Cancers that Manifest Microsatellite Instability [C] . Sigurdis Haraldsdottir, Richard M. Goldberg Gastrointestinal Cancers Symposium . 2014

机译：不应常规向患有阶段结肠癌的患者常规的辅助化学疗法，表明微卫星不稳定性
5. Adherence to adjuvant chemotherapy and post-treatment surveillance in a large community-based cohort of patients with colon cancer. [D] . Hu, Chung-Yuan. 2010

机译：在结肠癌患者的大型社区队列中坚持辅助化疗和治疗后监测。
6. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [O] . Thierry André, Timothy Iveson, Roberto Labianca, -1

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状
7. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [O] . Thierry André, null null, Timothy Iveson, 2013

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析，研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状

IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients

著录项

相似文献

相关主题

期刊订阅